(Q39267149)

English

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

author name string

S Zakko

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

G Barton

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

E Weber

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

C Dunger-Baldauf

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A Rühl

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

20 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1311-1321

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Functional bowel disorders and functional abdominal pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Abdominal pain impacts quality of life in women with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Irritable bowel syndrome: a technical review for practice guideline development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

CT and MRI of Lung Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]p

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Dual and selective antagonism of neurokinin NK(1) and NK(2) receptor-mediated responses in human colon mucosa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Review article: irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Evaluation of drug treatment in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04656.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2011.04656.X

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39267149&oldid=1817365070"